Join us for a lively and informative presentation focusing on the PTAB’s revised standard operating procedures – how cases are assigned to panels, the new POP panel for high-level review, and how decisions are nominated for designation or de-designation as precedential or informative – and what this all means to practitioners and patent holders.
Foley & Lardner – 3579 Valley Centre Dr # 300, San Diego, CA 92130
Food and drinks were provided.
About our speaker:
Courtenay Brinckerhoff is a partner in the Washington, D.C. office of Foley. She is vice chair of the firm’s Chemical, Biotechnology & Pharmaceutical Practice and a member of the firm’s Life Sciences Industry Team. She also is involved with Foley’s Life Sciences Licensing & Collaborations group and Personalized Medicine group. Her practice focuses on client counseling in all aspects of obtaining, licensing, and enforcing patents and conducting freedom-to-operate and due diligence investigations.
Ms. Brinckerhoff has represented clients before the U.S. Patent and Trademark Office, the U.S. Patent Office Board of Appeals and Interferences, and the U.S. Court of Appeals for the Federal Circuit. She works with clients in diverse industries, including pharmaceuticals (chemical and biotechnological), human and animal food products, nutraceuticals, and medical devices. For her work on this blog she was named a Readers’ Choice 2017 Top Author in the categories of Pharmaceutical Industry and Patents, respectively.